
MIDD0301
CAS No. 2187489-08-1
MIDD0301( MIDD 0301 | MIDD-0301 )
Catalog No. M13489 CAS No. 2187489-08-1
MIDD0301 is a potent, positive allosteric, α5β3γ2 selective, GABAA receptor (GABAAR) ligand with EC50 of 17 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 393 | Get Quote |
![]() ![]() |
10MG | 590 | Get Quote |
![]() ![]() |
25MG | 1060 | Get Quote |
![]() ![]() |
50MG | 1591 | Get Quote |
![]() ![]() |
100MG | 2387 | Get Quote |
![]() ![]() |
200MG | 3580 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMIDD0301
-
NoteResearch use only, not for human use.
-
Brief DescriptionMIDD0301 is a potent, positive allosteric, α5β3γ2 selective, GABAA receptor (GABAAR) ligand with EC50 of 17 nM.
-
DescriptionMIDD0301 is a potent, positive allosteric, α5β3γ2 selective, GABAA receptor (GABAAR) ligand with EC50 of 17 nM, shows no significant binding at the peripheral GABAAR at 10 uM; causes amplification of GABA induced current mediated by α1-3,5β3γ2 GABAARs in the presence of MIDD0301 in automated patch clamp test; relaxes airway smooth muscle at single micromolar concentrations as demonstrated with ex vivo guinea pig tracheal rings, also attenuates airway hyperresponsiveness (AHR) in an ovalbumin murine model of asthma by oral administration, with low brain distribution; reduces lung cytokine expression of IL-17A, IL-4, and TNF-α, as wells as the number of CD4+ T cells.
-
In Vitro——
-
In Vivo——
-
SynonymsMIDD 0301 | MIDD-0301
-
PathwayMembrane Transporter/Ion Channel
-
TargetGAT
-
RecptorGAT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2187489-08-1
-
Formula Weight414.234
-
Molecular FormulaC19H13BrFN3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (241.41 mM)
-
SMILES——
-
Chemical Name(R)-8-bromo-6-(2-fluorophenyl)-4-methyl-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Forkuo GS, et al. Mol Pharm. 2018 Apr 2. doi: 10.1021/acs.molpharmaceut.7b01013.
molnova catalog



related products
-
Nefiracetam
Nefiracetam is a GABAergic, cholinergic, and monoaminergic neuronal system enhancer for Ro 5-4864-induced convulsions. Phase 2.
-
PF-06372865
PF-06372865 is a novel potent, α2/3 functionally selective GABAA receptor positive allosteric modulator.
-
Lesogaberan
Lesogaberan (AZD-3355) is a potent, selective, peripherally acting GABAB receptor agonist with Ki of 5 nM and EC50 of 8.6 nM, 274-fold selectivity over GABAA (Ki=1.4 uM).